$0.90-0.05-5.26%USD

IM Cannabis Corp (IMCC) is a international cannabis company trading on the NASDAQ. The stock is currently priced at $0.90 with a market capitalization of $5.4M.

Market Cap

$5.4M

Volume

7.6K

Prev Close

$0.95

52W High

$7.12

52W Low

$0.65

P/S Ratio

N/A

Shares Out

6.0M

Revenue

N/A

Gross Margin

0.0%

Cash

N/A

IMCC Price Chart

Trading Data

Trading Data

Previous Close$0.95
Open$0.95
Day Range$0.65 – $7.12
52-Week Range$0.65 – $7.12
$0.65$7.12
Volume7.6K
Avg Volume7.6K
Market Cap$5.4M
Enterprise Value$5.4M
Shares Outstanding6.0M
P/S Ratio0.00
Revenue Growth YoY0.00%

Valuation Metrics

Valuation Metrics

P/S Ratio (TTM)
0.00Below 5x — attractive
EV / Revenue
vs industry avg ~8x
Gross Margin
0.0%Thin margins
Revenue Growth YoY
0.00%Revenue declining
Cash Runway
Debt-to-Equity

Financial Highlights

View Full Financials

Financial Highlights

R
Revenue TTM$0Trailing twelve months
G
Gross Profit$0Revenue x Margin
%
Gross Margin0.0%Thin profitability
$
Cash & Equivalents$0Available liquidity
D
Total Debt$0Outstanding obligations
N
Net Cash Position$0Cash minus debt

Quarterly Revenue

No quarterly revenue data available

IMCC Key Takeaways

  • IM Cannabis Corp (IMCC) trades at $0.90 with a market cap of $5.4M, ranking #73 among 100 cannabis stocks.
  • Balance sheet shows N/A cash against N/A debt — net debt position.
  • Ranked #2 by market cap in the International sector. Trades on the NASDAQ exchange.

IMCC Stock Analysis

IM Cannabis Corp (IMCC) is a international cannabis company listed on the NASDAQ exchange, headquartered in IL. With a current share price of $0.90 and a market capitalization of $5.4M, IMCC ranks #73 out of 100 publicly traded cannabis stocks tracked on Cannabismarketcap.

The company's balance sheet shows N/A in cash and equivalents against N/A in total debt, leaving net debt of N/A. Investors looking for a deeper dive can explore IMCC's full financial statements including quarterly breakdowns and balance sheet history.

IMCC currently trades within a 52-week range of $0.65 to $7.12. Average daily trading volume stands at 7.6K shares. The company employs approximately 55 people.

Corporate Information

Corporate Information

Company Name
IM Cannabis Corp
Ticker Symbol
IMCC
Exchange
NASDAQ
Sector
InternationalInternational
Industry
Headquarters
Israel
IPO / List Date
Feb 13, 1997
Employees
55
Market Cap
$5.4M#73 in cannabis
Shares Outstanding
6.0M
Status
Active
Currency
USD

Share Structure

Share Structure

Shares Outstanding
6.0M
Market Cap
$5.4M
Enterprise Value
$5.4M
Float (est.)
5.1M~85% of outstanding
Dilution Rate
Avg Volume
7.6K
Insider Ownership
N/AData pending
Institutional Ownership
N/AData pending
Short Interest
N/AData pending

IMCC Latest News

Latest News

No recent news available for IMCC

IMCC Price History

Investment Snapshot

Investment Snapshot

Programmatic analysis based on available financial data. Not investment advice.

Market PositionCaution

Ranked #73 of 100 by market cap ($5.4M). Sector median: $32.7M.

Financial HealthNeutral

Gross margin at 0.0%.

GrowthNeutral

Revenue growth at +0.0% YoY. Sector median: +0.0%.

ValuationPositive

P/S ratio of 0.00x vs sector median of 1.83x. Potentially undervalued.

Cannabis Industry Context

Cannabis Industry Overview

The global cannabis market extends well beyond North America, with an increasing number of countries establishing medical cannabis programs and, in some cases, moving toward regulated adult-use frameworks. Germany has emerged as the largest medical cannabis market in Europe and is pursuing a landmark recreational legalization model that could set precedent for the broader European Union. Other European markets with active medical cannabis programs include Poland, the Czech Republic, Italy, Portugal, and the United Kingdom. In the Asia-Pacific region, Australia and Thailand have developed distinct regulatory approaches, with Thailand becoming the first Southeast Asian country to decriminalize cannabis. Latin American markets — particularly Colombia, Uruguay, and Mexico — offer low-cost cultivation environments and varying degrees of legal market structure. International cannabis companies navigate a complex web of country-specific regulations, EU-GMP certification requirements, import/export licensing, and currency risk. Investors in this segment evaluate geographic diversification, regulatory moat in early-mover markets, supply agreements with established healthcare distributors, and the timeline for market maturation in each jurisdiction.

IM Cannabis Corp in the International Cannabis Landscape

IM Cannabis Corp (IMCC) currently ranks #2 out of 4 publicly traded international cannabis companies by market capitalization, with a market cap of $5.4M. Revenue data is not currently available for this company. The international cannabis sector comprises 4 tracked companies, reflecting the focused competitive landscape within this segment of the cannabis industry.

The top companies in the international cannabis sector by market capitalization are Blueberries Medical Corp (BBRRF) at $6.0M, IM Cannabis Corp (IMCC) at $5.4M, and Akanda Corp (AKAN) at $1.7M. IM Cannabis Corp competes within this group for market share, investor attention, and operational scale as the sector continues to mature.

Key Metrics at a Glance

Market Cap$5.4MSector median: $3.6M
Revenue (TTM)N/ASector median: N/A
Gross MarginN/ASector median: N/A
P/S RatioN/ASector median: N/A

Regulatory & Risk Considerations

All cannabis investors should be aware that federal legalization status in the United States remains uncertain. While cannabis is legal for medical use in the majority of US states and for adult use in a growing number of jurisdictions, it remains classified as a Schedule I controlled substance at the federal level. This creates material legal, financial, and operational risks across the industry. International cannabis operators like IM Cannabis Corp must navigate a patchwork of country-specific regulations that can change rapidly as governments refine their cannabis policies. Import/export licensing, EU-GMP certification requirements, and in-country distribution agreements all require significant time and capital investment, with no guarantee of regulatory continuity.

Currency risk is a material consideration for international operators generating revenue across multiple jurisdictions. Political risk also varies significantly by country — regulatory rollbacks, changes in government, or shifts in public sentiment can disrupt market access. Companies operating in emerging cannabis markets may also face challenges around intellectual property protection, local partner reliability, and the development of compliant supply chains in jurisdictions with limited cannabis-specific infrastructure.

IMCC Key Takeaways

  • IM Cannabis Corp has a market cap of $5.4M, making it a small-cap cannabis company listed on the NASDAQ.
  • Trailing twelve-month revenue is $0 with year-over-year growth of 0.0%. Declining revenue is a concern that warrants attention.
  • The company's gross margin stands at 0.0%. Low or negative margins raise questions about pricing power and cost structure.
  • IM Cannabis Corp holds $0 in cash against $0 in debt, resulting in a net debt position of $0 and an estimated 0.0 months of cash runway.
  • The stock trades at a P/S ratio of 0.00x and EV/Revenue of 0.00x. Relatively low multiples could indicate an undervalued opportunity.
  • At $0.90, the stock trades at 4% of its 52-week range ($0.65 – $7.12). Trading near yearly lows could present value for contrarian investors.
  • The annual share dilution rate is 0.0%. Low dilution is a positive sign of disciplined capital management.

IM Cannabis Corp Stock Analysis

IM Cannabis Corp (NASDAQ: IMCC) is a international cannabis company currently trading at $0.90 per share with a market capitalization of $5.4M. The stock declined -5.26% in the most recent trading session on volume of 7.6K shares. IM Cannabis Corp is headquartered in the United States and employs approximately 55 people. As a participant in the international cannabis segment, the company operates within one of the most dynamic and rapidly evolving sectors of the North American economy.

On the revenue front, IM Cannabis Corp generated $0 in trailing twelve-month (TTM) revenue, reflecting year-over-year growth of 0.0%. This growth rate is trailing the International sector average of 0.0%. IM Cannabis Corp currently operates with a negative gross margin of 0.0%, meaning the company's cost of goods sold exceeds its revenue. This is a significant concern and suggests the business needs to either increase prices, reduce production costs, or achieve greater economies of scale. Revenue trends in the cannabis industry are closely watched by analysts, as the sector continues to navigate pricing compression, oversupply dynamics in certain markets, and the ongoing burden of IRS Section 280E, which prevents cannabis businesses from deducting ordinary business expenses at the federal level.

From a valuation perspective, IM Cannabis Corp trades at a price-to-sales (P/S) ratio of 0.00x, which is below the sector median of 0.00x, which could indicate the stock is undervalued relative to peers or that the market has concerns about the company's growth trajectory. The enterprise value-to-revenue (EV/Revenue) multiple stands at 0.00x. Cannabis stock valuations have compressed significantly from their 2021 highs, and current multiples reflect a more mature market environment where investors demand clear paths to profitability. For context, the broader International sector contains 4 publicly traded companies tracked by CannaCap, and IM Cannabis Corp's valuation should be considered within the context of its specific growth profile and competitive positioning.

IM Cannabis Corp carries net debt of $0, with $0 in total debt against $0 in cash and equivalents. At the current pace, the company has an estimated 0.0 months of cash remaining, making capital management a critical near-term priority. Access to capital remains a persistent challenge for cannabis companies, particularly plant-touching operators that are excluded from traditional banking services and institutional lending. Many cannabis companies have turned to sale-leaseback transactions, private placements, and at-the-market (ATM) equity offerings to fund operations. IM Cannabis Corp's balance sheet should be evaluated with these industry-specific constraints in mind.

Key risk factors for IM Cannabis Corp investors include the ongoing federal prohibition of cannabis in the United States, which creates regulatory uncertainty and limits access to capital markets. The company has maintained relatively low share dilution at 0.0% annually, which is favorable for existing shareholders and indicates disciplined capital management. The stock currently trades at $0.90, which is 4% of the way between its 52-week low of $0.65 and its 52-week high of $7.12. Additional industry-wide risks include potential state-level regulatory changes, evolving consumer preferences, price compression from increased competition, and the impact of illicit market activity on legal operators. The Section 280E tax burden continues to weigh on cannabis company profitability, and any federal rescheduling or descheduling of cannabis would be a significant catalyst for the entire sector.

The cannabis industry is at a pivotal juncture, with potential federal reform, state-level market expansion, and increasing institutional interest all shaping the investment landscape. IM Cannabis Corp, with its $5.4M market cap and $0 revenue base, is positioned as a smaller player in the international cannabis space. Investors considering IMCC should weigh the company's financial metrics against the broader opportunity set within the cannabis sector, which includes 100 publicly traded companies tracked on CannaCap with a combined market capitalization measured in the tens of billions of dollars.

IMCC Price Performance

IM Cannabis Corp (IMCC) currently trades at $0.90, which places the stock at approximately 4% of its 52-week trading range. Over the past twelve months, IMCC has traded as high as $7.12 and as low as $0.65, representing a 995.4% spread between the yearly high and low. The current price sits 87.4% below the 52-week high and 38.5% above the 52-week low. This range provides important context for understanding the stock's recent volatility and where current levels fall within the broader price history.

In the most recent trading session, IMCC fell -5.26% from a previous close of $0.95 to $0.90, on volume of 7.6K shares. This negative session represents a significant single-day move that may have been driven by company-specific news, sector-wide sentiment, or broader market dynamics. The stock has 6,000,000 shares outstanding, giving it a fully diluted market capitalization that investors should factor into their analysis alongside the current $5.4M market cap figure.

Cannabis stocks have historically exhibited significant price volatility driven by regulatory developments, earnings surprises, and shifts in market sentiment toward the sector. IMCC is trading in the lower portion of its 52-week range, which could represent a value opportunity for contrarian investors, or may reflect deteriorating fundamentals that warrant caution. Historical price levels should be considered alongside fundamental data — including revenue trends, margin improvement, and balance sheet health — to form a complete investment thesis.

How to Invest in IM Cannabis Corp

IM Cannabis Corp (IMCC) is listed on the NASDAQ stock exchange, one of the largest and most liquid equity markets in the world. NASDAQ-listed stocks can be purchased through virtually any U.S. brokerage account, including online platforms such as Fidelity, Charles Schwab, TD Ameritrade, Robinhood, and Interactive Brokers. To purchase shares of IMCC, you will need a brokerage account that supports trading on the NASDAQ. The stock currently trades at $0.90 per share with an average daily volume of 7.6K shares, which provides limited liquidity for most retail investors. When placing an order, consider using limit orders rather than market orders to control your entry price, especially during periods of high volatility.

Investors evaluating IM Cannabis Corp should closely monitor several key financial metrics. The company's trailing twelve-month revenue of $0 and year-over-year revenue growth of 0.0% provide insight into top-line momentum. The gross margin of 0.0% indicates how efficiently the company converts revenue into gross profit. On the balance sheet, IM Cannabis Corp holds $0 in cash against $0 in total debt, giving it approximately 0.0 months of operating runway. The price-to-sales ratio of 0.00x and enterprise value-to-revenue of 0.00x help contextualize the stock's valuation relative to its revenue generation. Watch quarterly earnings reports for trends in these metrics, as well as any changes to guidance or strategic direction.

When comparing IM Cannabis Corp to other cannabis investments, consider the company's sector (International Cannabis), geographic focus (United States), and stage of growth. As a small-cap cannabis company, IM Cannabis Corp carries higher risk but may offer greater upside potential if the company executes on its growth strategy. The cannabis sector is highly fragmented, and understanding where a company fits within the broader competitive landscape — including its market share, geographic footprint, and product differentiation — is essential for making informed investment decisions.

Important risk disclosure: Cannabis stocks carry unique risks beyond those of typical equity investments. Federal illegality in the United States creates regulatory, banking, and tax challenges (particularly Section 280E). State-by-state legalization creates a patchwork of market opportunities and compliance requirements. Cannabis companies frequently issue additional shares to fund operations, which dilutes existing shareholders — IM Cannabis Corp's current dilution rate is 0.0% annually. Past performance is not indicative of future results, and investors should only allocate capital they can afford to lose. This content is for informational purposes only and does not constitute investment advice. Always conduct your own due diligence and consider consulting a financial advisor before investing in cannabis stocks.

Compare IMCC With Peers

Peer Comparison

CompanyPriceChange %Mkt CapRevenueMarginP/S
IMCC$0.90-5.26%$5.4M$00.0%0.00
BBRRF$0.01+19.19%$6.0M$00.0%0.00
AKAN$0.82-2.84%$1.7M$00.0%0.00
CSUI$0.010.00%$848.4K$00.0%0.00

Related International Stocks

Frequently Asked Questions

What is IM Cannabis Corp's (IMCC) stock price today?

IM Cannabis Corp (IMCC) stock is currently trading at $0.90 per share on the NASDAQ exchange. This represents a daily decline of -5.26% ($0.05) from the previous closing price of $0.95. Over the past 52 weeks, IMCC has traded between a low of $0.65 and a high of $7.12, placing the current price at approximately -87% from its annual high. The stock has a market capitalization of $5.4M, making it a notable cannabis companies tracked by Cannabismarketcap. IM Cannabis Corp operates in the International sector, serving the broader cannabis industry.

What is IM Cannabis Corp's market capitalization?

IM Cannabis Corp (IMCC) has a current market capitalization of $5.4M, calculated by multiplying its 6.0M shares outstanding by the current stock price of $0.90. Market capitalization is a key measure of a company's total equity value as perceived by the public market, and it places IM Cannabis Corp among the small-cap cannabis companies tracked on Cannabismarketcap. For context, the enterprise value (market cap plus debt minus cash) stands at $5.4M, which accounts for the company's balance sheet structure. Investors often use market cap alongside revenue and profitability metrics to assess relative valuation within the cannabis sector.

Is IM Cannabis Corp profitable?

IM Cannabis Corp (IMCC) currently reports a gross margin of 0.0%, which means the company loses 0.0 cents of every revenue dollar after direct costs of goods sold. Profitability is a critical factor in the cannabis industry, where many companies are still investing heavily in growth and regulatory compliance. Investors should review the full income statement, cash flow trends, and operating expense breakdown on Cannabismarketcap for a complete picture of IM Cannabis Corp's financial health.

What are IM Cannabis Corp's key financial metrics?

IM Cannabis Corp (IMCC) reports several important financial metrics that investors track closely. The company has a market capitalization of $5.4M, trailing twelve month revenue of N/A, and a gross margin of 0.0%. On the balance sheet, IM Cannabis Corp holds $0 in cash and equivalents against $0 in total debt, resulting in a debt-to-market-cap ratio of 0.00x. With 6.0M shares outstanding, investors should consider both the fundamental financial performance and share structure when evaluating IMCC.

How many employees does IM Cannabis Corp have?

IM Cannabis Corp currently employs approximately 55 people across its operations. As a International cannabis company headquartered in IL, its workforce supports activities spanning related business functions. Employee count is an important indicator of a company's operational scale and its capacity for growth in an industry that remains highly labor-intensive due to regulatory requirements.

What exchange is IMCC listed on?

IM Cannabis Corp trades under the ticker symbol IMCC on the NASDAQ exchange, and the stock is denominated in US dollars (USD). Shares can typically be purchased through most standard brokerage accounts. The company has been publicly listed since 1997-02-13, giving it a track record in the public markets that investors can analyze for long-term trends. The stock sees average daily trading volume of approximately 7.6K shares, which is an important consideration for liquidity and the ability to enter or exit positions without significant price impact.

What sector is IM Cannabis Corp in?

IM Cannabis Corp is classified as a International company within the cannabis industry, meaning it operates in cannabis markets outside of North America, including European, South American, or Asia-Pacific markets. The International sector is a key segment of the cannabis market, and investors often compare companies within the same sector to identify relative outperformers. You can compare IMCC with other International stocks on Cannabismarketcap's sector page to see how it ranks on metrics like market cap, revenue, and margins.

What is IM Cannabis Corp's gross margin?

IM Cannabis Corp (IMCC) has a gross margin of 0.0%, which represents the percentage of revenue the company retains after paying for the direct cost of goods sold. Gross margin is a critical profitability indicator in the cannabis industry, where companies face unique cost pressures from regulatory compliance, testing requirements, and the tax burden of IRC Section 280E (which prevents cannabis companies from deducting standard business expenses). A negative gross margin like IM Cannabis Corp's suggests the company is facing challenges in cost management or pricing.

How does IMCC compare to other cannabis stocks?

You can compare IM Cannabis Corp (IMCC) side-by-side with any cannabis stock on Cannabismarketcap using the dedicated comparison tool. Key comparison metrics include market cap ($5.4M), trailing twelve month revenue (N/A), gross margin (0.0%), and price-to-sales ratio (N/A). IM Cannabis Corp sits in the International sector, so the most relevant peer comparisons would be against other International companies, though cross-sector comparisons can also reveal interesting insights about relative valuation. Visit the rankings page to see where IMCC stands across all cannabis companies on metrics like revenue growth (0.00% YoY), cash position ($0), and employee count (55).

What is IMCC's 52-week trading range?

IM Cannabis Corp (IMCC) has traded between a 52-week low of $0.65 and a 52-week high of $7.12, with the current price of $0.90 sitting approximately -87% from the annual high. This range represents a spread of $6.47 (995% from low to high), which reflects the volatility the stock has experienced over the past year. The 52-week range is a commonly used technical indicator that helps investors understand whether a stock is trading near the top or bottom of its recent range, and it can inform decisions about entry and exit points. Cannabis stocks in general tend to exhibit higher volatility than broader market indices due to evolving regulations and market sentiment.

How does IM Cannabis Corp's valuation compare to cannabis industry peers?

IM Cannabis Corp (IMCC) is valued at a market capitalization of $5.4M, and an enterprise value of $5.4M. In the cannabis industry, valuations can vary significantly depending on sector (MSO, LP, Ancillary, etc.), growth rate, and path to profitability. IM Cannabis Corp's current revenue trajectory of 0.00% YoY may result in a lower valuation relative to faster-growing peers. Investors can use the Cannabismarketcap rankings and comparison tools to benchmark IMCC against specific competitors on valuation multiples, growth rates, and profitability.

What is IM Cannabis Corp's enterprise value?

IM Cannabis Corp (IMCC) has an estimated enterprise value (EV) of $5.4M, which is calculated by taking the market capitalization of $5.4M, adding total debt of $0, and subtracting cash and equivalents of $0. Enterprise value is widely considered a more comprehensive measure of a company's total value than market cap alone because it accounts for the capital structure, including debt obligations and available liquidity. For cannabis companies in particular, where balance sheet health varies dramatically, enterprise value provides a more accurate picture of acquisition cost and relative valuation.

Is IM Cannabis Corp stock overvalued or undervalued?

Determining whether IM Cannabis Corp (IMCC) is overvalued or undervalued requires analyzing multiple valuation metrics in context. The stock is currently trading at $0.90, which is -87% from its 52-week high of $7.12, with a gross margin of 0.0%. Investors should consider the company's enterprise value of $5.4M, its cash position of $0, and the broader cannabis industry outlook when forming a valuation opinion. Cannabismarketcap provides all the data needed for a thorough analysis, but this information should not be considered investment advice.

What are the risks of investing in IM Cannabis Corp?

Investing in IM Cannabis Corp (IMCC) carries several risks that investors should carefully consider. First, the cannabis industry remains federally illegal in the United States, creating regulatory uncertainty that can impact stock prices, banking access, and tax obligations (notably IRC Section 280E). Second, IM Cannabis Corp's balance sheet shows $0 in total debt against $0 in cash, which investors should monitor for dilution risk or liquidity concerns. Additionally, the stock has shown a 52-week range of $0.65 to $7.12, reflecting meaningful price volatility. As with all cannabis stocks, investors face risks from changing state regulations, competitive pressures, and the evolving legal landscape. This information is for educational purposes only and is not investment advice.

What is IM Cannabis Corp's cash position and debt level?

IM Cannabis Corp (IMCC) holds $0 in cash and equivalents on its balance sheet, set against $0 in total debt. This gives the company a net debt position of $0. Balance sheet strength is especially important in the cannabis industry, where companies often face limited access to traditional banking and capital markets. Investors should track these metrics over time on Cannabismarketcap to identify trends in cash consumption and debt management.

How many shares outstanding does IM Cannabis Corp have?

IM Cannabis Corp (IMCC) currently has 6.0M shares outstanding, which when multiplied by the current stock price of $0.90 gives the company its market capitalization of $5.4M. Share count is important because all per-share metrics (earnings per share, book value per share, etc.) are directly impacted by changes in shares outstanding. Cannabis companies frequently issue new shares to raise capital, so monitoring dilution trends on Cannabismarketcap is recommended for long-term investors.

Does IM Cannabis Corp pay a dividend?

Most cannabis companies, including IM Cannabis Corp (IMCC), do not currently pay dividends. The cannabis industry is still in a growth phase, and companies typically reinvest available capital into expanding operations, securing new licenses, building out retail and cultivation infrastructure, and navigating complex regulatory requirements. Additionally, the IRC Section 280E tax burden significantly reduces the free cash flow available for shareholder distributions. Investors in cannabis stocks should generally expect returns to come from capital appreciation rather than dividend income. If IM Cannabis Corp initiates a dividend in the future, it would be reported in their SEC filings and reflected on Cannabismarketcap.

How can I research IM Cannabis Corp stock before investing?

To research IM Cannabis Corp (IMCC) before investing, start with the company overview on Cannabismarketcap, which provides current price ($0.90), market cap ($5.4M), and key financial metrics. Next, review the full financial statements page for quarterly revenue trends, margins, and balance sheet details. Check the analyst ratings page for Wall Street consensus and price targets, and the technical analysis page for chart patterns and momentum indicators. Compare IMCC against sector peers using the comparison tool to understand relative valuation. Review recent news coverage for regulatory developments or corporate events. Finally, read the investment analysis page for a comprehensive deep-dive. Cannabis investing carries unique risks including federal illegality, regulatory uncertainty, and limited banking access — always conduct thorough due diligence before making any investment decision.

What does IM Cannabis Corp's market cap of $5.4M mean?

IM Cannabis Corp's market capitalization of $5.4M represents the total market value of all its outstanding shares (6.0M shares multiplied by the current stock price of $0.90). Market cap is the primary measure investors use to classify companies by size: small-cap companies (under $100M) like IM Cannabis Corp may offer higher growth potential but come with greater risk and lower liquidity. In the cannabis sector, market cap is especially important because it determines index weighting, institutional investment eligibility, and often correlates with the company's operational scale and geographic reach. IM Cannabis Corp currently ranks # among cannabis stocks tracked on Cannabismarketcap.

What regulatory risks does IM Cannabis Corp face?

IM Cannabis Corp (IMCC), like all cannabis companies, faces significant regulatory risks that investors should understand. At the federal level, cannabis remains a Schedule I controlled substance in the United States, which restricts banking access, prevents standard business expense deductions under IRC Section 280E, and creates legal uncertainty. IM Cannabis Corp is subject to the evolving regulatory landscape across the jurisdictions where it operates. Potential catalysts include federal rescheduling (which could ease 280E burdens), the SAFE Banking Act (which would improve banking access), and individual state legalization events. Conversely, regulatory setbacks such as license moratoriums, increased enforcement, or unfavorable tax policy changes pose downside risks. Investors should monitor legislative developments closely using Cannabismarketcap's news and legalization tracker.

IM Cannabis Corp (IMCC) is a international cannabis company listed on the NASDAQ exchange, headquartered in IL. With a market capitalization of $5.4M, IM Cannabis Corp ranks #73 among all 100 publicly traded cannabis companies tracked on Cannabismarketcap. The stock is currently trading at $0.90, representing a loss of -5.26% today on volume of 7.6K shares. For real-time price tracking and analysis, see our IMCC news page and financial statements.

Investors researching IMCC can access detailed financial data including revenue, margins, and balance sheet metrics. For broader market context, explore the International sector overview, browse all NASDAQ-listed cannabis stocks, or view the market cap rankings, revenue rankings, and P/S ratio rankings. Use the stock screener to filter cannabis stocks by any metric.

Compare IM Cannabis Corp head-to-head with other cannabis stocks using our comparison tool. Popular comparisons include IMCC vs BBRRF, IMCC vs AKAN, and IMCC vs CSUI. Track IMCC alongside the entire cannabis market with Cannabismarketcap's comprehensive gross margin rankings, cash position rankings, and valuation rankings.

New to cannabis investing? Learn about the industry with our guides on cannabis stock basics, how to evaluate cannabis stocks, and industry overview. Cannabismarketcap tracks every publicly traded cannabis company with real-time pricing, detailed financials, and programmatic analysis to help investors make informed decisions.

Embed IMCC Widget

Add the IMCC price widget to your website or blog:

<iframe src="https://cannabismarketcap.io/embed/imcc" width="320" height="180" frameborder="0" style="border-radius:8px;border:1px solid #415a77"></iframe>

Data updates every 2 minutes. Free for non-commercial use.

Disclaimer

The information on this page is provided for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Cannabismarketcap is not a registered broker-dealer or investment advisor. All data, including stock prices, market capitalizations, financial metrics, and analysis for IM Cannabis Corp (IMCC), is provided “as is” without warranty of any kind. Past performance does not guarantee future results. Cannabis stocks are highly volatile and carry significant risk, including the potential for total loss of investment. Marijuana remains illegal under federal law in the United States. Always conduct your own due diligence and consult a qualified financial advisor before making investment decisions. Data may be delayed or inaccurate. See our terms of service and privacy policy for more information.